Stock Market & Financial Investment News

News Breaks November 16, 2012 05:46 EDT ATRC AtriCure upgraded to Overweight from Neutral at Piper Jaffray Piper Jaffray upgraded AtriCure citing confidence in new management after meeting with the company's new CEO Michael Carrel. Piper raised its price target for shares to $10 from $6. News For ATRC From The Last 14 Days Check below for free stories on ATRC the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. There are no results for ATRC Sign up for a free trial to see the rest of the stories you've been missing.